ARCHIVES

Letter: Medicare Policy May Delay Access to Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 29 No. 24 | June 13, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Management Director Leaving For Case Institute.

October 12, 2001

Cancer Groups Endorse Pazdur For FDA Commissioner.

January 19, 2001

National Toxicology Program: Saccharin No Longer Listed as Carcinogen in NTP Report

May 19, 2000

Archival photos: Senator Ernest “Fritz” Hollings, namesake of MUSC Hollings Cancer Center

February 2, 2021

Report Criticizes NIH Grant Review

June 16, 1995

Stimulus Bill Gives NIH A $10 Billion Boost Over Two Years, Puts Pressure On Institutes to Make Rapid Funding Decisions

February 13, 2009